These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28439897)

  • 41. Donor platelet response and product quality assurance in plateletpheresis.
    Lasky LC; Lin A; Kahn RA; McCullough J
    Transfusion; 1981; 21(3):247-60. PubMed ID: 7233509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors influencing yield of plateletpheresis using intermittent flow cell separator.
    DAS SS; Chaudhary RK; Shukla JS
    Clin Lab Haematol; 2005 Oct; 27(5):316-9. PubMed ID: 16178912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
    Katz L; Palmer K; McDonnell E; Kabat A
    Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human platelet lysate as a promising growth-stimulating additive for culturing of stem cells and other cell types.
    Shanskii YD; Sergeeva NS; Sviridova IK; Kirakozov MS; Kirsanova VA; Akhmedova SA; Antokhin AI; Chissov VI
    Bull Exp Biol Med; 2013 Nov; 156(1):146-51. PubMed ID: 24319712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD4+ T-cell lymphopenia in frequent platelet donors who have ceased platelet donation for at least 1 year.
    Rahmani M; Fortin BM; Berliner N; Issa N; Neuberg D; Kaufman RM; Gansner JM
    Transfusion; 2019 May; 59(5):1644-1647. PubMed ID: 30747442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Economic impact of donor platelet count and platelet yield in apheresis products: relevance for emerging issues in platelet transfusion therapy.
    Goodnough LT; Ali S; Despotis G; Dynis M; DiPersio JF
    Vox Sang; 1999; 76(1):43-9. PubMed ID: 9933853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microparticle content of platelet concentrates is predicted by donor microparticles and is altered by production methods and stress.
    Maurer-Spurej E; Larsen R; Labrie A; Heaton A; Chipperfield K
    Transfus Apher Sci; 2016 Aug; 55(1):35-43. PubMed ID: 27470708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective cell support by repeat plateletpheresis of related donors on the IBM 2997 cell separator.
    Langley JW; Spiva D; Hendren D; Orrell J
    Am J Clin Pathol; 1981 Aug; 76(2):148-54. PubMed ID: 7270495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemoglobin and platelet count effect on platelet yields in plateletpheresis.
    Guerrero-Rivera S; Gutiérrez-Espíndola G; Talavera JO; Meillón-García LA; Pedraza-Echevarría M; Pizzuto-Chávez J
    Arch Med Res; 2003; 34(2):120-3. PubMed ID: 12700007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of plateletpheresis on blood coagulation parameters in healthy donors at National Blood Centre, Kuala Lumpur, Malaysia.
    Siti Nadiah AK; Nor Asiah M; Nur Syimah AT; Normi M; Anza E; Aini AN; Mohd Zahari TH; Shahnaz M; Faraizah AK; Faisal MA
    Transfus Apher Sci; 2013 Dec; 49(3):507-10. PubMed ID: 24055412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Switching iron-deficient whole blood donors to plateletpheresis.
    O'Meara A; Infanti L; Sigle J; Stern M; Buser A
    Transfusion; 2012 Oct; 52(10):2183-8. PubMed ID: 22404849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Collection of hyperconcentrated platelets with Trima Accel.
    Ringwald J; Duerler T; Frankow O; Zimmermann R; Zingsem J; Strasser E; Antoon M; Eckstein R
    Vox Sang; 2006 Feb; 90(2):92-6. PubMed ID: 16430666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeat plateletpheresis: the effects on the donor and the yield.
    Rock G; Tittley P; Sternbach M; Buskard N; Schroeder M
    Vox Sang; 1992; 63(2):102-6. PubMed ID: 1441301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of PEG-rhuMGDF in platelet apheresis.
    Kuter DJ
    Stem Cells; 1998; 16 Suppl 2():231-42. PubMed ID: 11012195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative Analysis of Various Aspects of Plateletpheresis on the Fenwal Amicus and Fresenius COM.TEC Cell Separator Instruments.
    Philip J; Biswas AK; Chatterjee T; Mallhi RS
    Lab Med; 2014; 45(4):315-23. PubMed ID: 25316663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of plateletpheresis on total platelet count and mean platelet volume: A meta-analysis.
    Gil-Betancur A; Mantilla-Gutierrez CY; Cardona-Arias JA
    J Evid Based Med; 2020 Aug; 13(3):206-214. PubMed ID: 32615026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum ferritin in plateletpheresis and whole blood donors.
    Duggan F; O'Sullivan K; Power JP; Healy M; Murphy WG
    Transfus Apher Sci; 2016 Aug; 55(1):159-63. PubMed ID: 27339300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Equine autologous platelet concentrates: A comparative study between different available systems.
    Hessel LN; Bosch G; van Weeren PR; Ionita JC
    Equine Vet J; 2015 May; 47(3):319-25. PubMed ID: 24773596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feasibility of applying the 2day deferral for repeat plateletpheresis: Indian perspective.
    Nomani L; Raina TR; Sidhu M
    Transfus Apher Sci; 2013 Jun; 48(3):341-3. PubMed ID: 23643473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.